Apoptosis and the cell cycle

Current Opinion in Cell Biology

Volumn 7, Issue 6, 1995, Pages 825-834

  Evan, Gerard I ^a   Brown, Lamorna ^a   Whyte, Moira ^a   Harrington, Elizabeth ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYTOKINE; DNA; INTERLEUKIN 1BETA; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

APOPTOSIS; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; DNA DAMAGE; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMAL; APOPTOSIS; CELL CYCLE;

EID: 0028844170     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-0674(95)80066-2     Document Type: Article

References (84)

1. Death by suicide: one way to go in mammalian cellular development?
2. Apoptosis: mechanisms and roles in pathology
3. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins
4. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
5. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins
6. Induction of apoptosis in fibroblasts by c-myc protein
7. The c-Myc protein induces cell cycle progression and apoptosis through dimerisation with Max
8. Binding and suppression of the Myc transcriptional activation domain by p107
9. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.
10. Oncogenes and cell death
11. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius
12. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy
13. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus
14. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
15. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
16. Cooperative interaction between c-myc and bcl-2 proto-oncogenes
17. G1 events and regulation of cell proliferation
18. The retinoblastoma gene and gene product
19. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro
20. The E2F transcription factor is a cellular target for the RB protein
21. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
22. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F
23. E2F—a link between the Rb tumor suppressor protein and viral oncoproteins
24. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
25. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
26. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis
27. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
28. p53 and E2F-1 cooperate to mediate apoptosis
29. Requirement for a functional Rb-1 gene in murine development
30. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
31. Effects of an Rb mutation in the mouse
32. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
33. Inhibition of apoptosis by the retinoblastoma gene product.
34. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB
35. Cells differentiating into neuroectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins
36. Social controls on cell survival and cell death
37. Programmed cell death and the control of cell survival: lessons from the nervous system
38. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
39. Modulation of Myc-induced apoptosis by specific cytokines
40. Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog
41. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
42. Premature p34cdc2 activation required for apoptosis
43. PITSLRE protein kinase activity is associated with apoptosis
44. Activation of cyclin A-dependent protein kinases during apoptosis
45. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells
46. Unscheduled activation of cyclin B1/Cd2c kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage
47. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase
48. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death
49. Cdc2 activation is not required for thymocyte apoptosis
50. Inactivation of cdc2 increases the level of apoptosis induced by DNA-damage
51. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
52. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines
53. Differential modulation of cyclin gene expression by MYC.
54. Participation of cyclin A in Myc-induced apoptosis
55. Apoptosis. Its significance in cancer and cancer therapy
56. Cancer. A deadly inheritance
57. p53 mutations in human cancers
58. Participation of p53 protein in the cellular response to DNA damage
59. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
60. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
61. 1 arrest and apoptosis
62. 1 cyclindependent kinases
63. p21 is a universal inhibitor of cyclin kinases
64. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes
65. 1 arrest and long-term induction of a Cip1 in normal human fibroblasts
66. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development
67. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
68. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
69. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
70. Mediation of c-Myc-induced apoptosis by p53
71. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
72. Wild-type p53 restores cell cycle and inhibits gene amplification in cells with mutant p53 alleles
73. Genetic instability as a consequence of inappropriate entry into and Progression through S-phase
74. p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts
75. Direct involvement of p53 in programmed cell death of oligodendrocytes
76. High frequency developmental abnormalities in p53-deficient mice
77. Induction of apoptosis by the Bcl-2 homologue Bak
78. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak
79. Cloning of a novel bcl-2 homologue by interaction with adnovirus E1B 19K
80. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
81. Cleavage of poly(adp-ribose) polymerase by a proteinase with properties like ICE
82. Nuclear events of apoptosis in vitro in cell-free mitotic extracts—a model system for analysis of the active phase of apoptosis
83. Yama/CPP32β, a mammalian homolog of CED-3 is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-Ribose) polymerase
84. Bax-deficient mice with lymphoid hyperplasia and male germ cell death